OS Therapies Statistics
Total Valuation
OS Therapies has a market cap or net worth of $34.41 million. The enterprise value is $32.55 million.
Important Dates
The next estimated earnings date is Thursday, May 15, 2025, before market open.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OS Therapies has 21.24 million shares outstanding. The number of shares has decreased by -6.42% in one year.
| Current Share Class | 21.24M |
| Shares Outstanding | 21.24M |
| Shares Change (YoY) | -6.42% |
| Shares Change (QoQ) | +165.35% |
| Owned by Insiders (%) | 31.48% |
| Owned by Institutions (%) | 0.68% |
| Float | 13.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -48.66 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76
| Current Ratio | 0.76 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.13 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -237.78% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 824.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.85M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.96 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 43.39 |
| Average Volume (20 Days) | 122,668 |
Short Selling Information
The latest short interest is 8,931, so 0.04% of the outstanding shares have been sold short.
| Short Interest | 8,931 |
| Short Previous Month | n/a |
| Short % of Shares Out | 0.04% |
| Short % of Float | 0.06% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | -5,154 |
| Operating Income | -5.00M |
| Pretax Income | n/a |
| Net Income | -7.42M |
| EBITDA | -5.00M |
| EBIT | -5.00M |
| Earnings Per Share (EPS) | -$0.76 |
Full Income StatementBalance Sheet
The company has $1.86 million in cash and n/a in debt, giving a net cash position of $1.86 million or $0.09 per share.
| Cash & Cash Equivalents | 1.86M |
| Total Debt | n/a |
| Net Cash | 1.86M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | -707,127 |
| Book Value Per Share | -0.03 |
| Working Capital | -613,787 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.78 million and capital expenditures $19, giving a free cash flow of -$5.78 million.
| Operating Cash Flow | -5.78M |
| Capital Expenditures | 19 |
| Free Cash Flow | -5.78M |
| FCF Per Share | -$0.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |